Platform technologies could deliver a vaccine quickly
Developing vaccines is expensive, risky, and time-consuming due to stringent approval processes and logistical challenges. Platform technologies for vaccines, which can be adapted quickly for different pathogens, offer a promising solution. However, current legal regimes are not equipped to evaluate these platforms, and regulators must gain experience with them to accelerate approvals.
